Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Capital International Investors | TFII TFI International Inc. | 13G/A | 5.1% | Aug 30, 2024 | 2y |
| Robert Anthony Wilson | SGRP SPAR Group, Inc. | 13D | 20.2% | Aug 30, 2024 | 2y |
| Scilex Holding Company | SMNR Semnur Pharmaceuticals, Inc. | 13D | 39.9% | Aug 30, 2024 | 2y |
| Invesco Ltd. | YUMC Yum China Holdings, Inc. | 13G/A | 2.2% | Aug 30, 2024 | 2y |
| Beryl Capital Management LLC | SEG Seaport Entertainment Group Inc. | 13G | 6.9% | Aug 30, 2024 | 2y |
| Capital Research Global Investors | TIXT TELUS International (Cda) Inc. Subordinate Voting Shares | 13G/A | 7.7% | Aug 30, 2024 | 2y |
| MORGAN STANLEY | OM Outset Medical, Inc. | 13G/A | 1.4% | Aug 30, 2024 | 2y |
| Capital World Investors | TNDM Tandem Diabetes Care Inc | 13G/A | 5% | Aug 30, 2024 | 2y |
| WELLINGTON MANAGEMENT GROUP LLP | AKRO Akero Therapeutics, Inc. Common Stock | 13G/A | 10.12% | Aug 30, 2024 | 2y |
| Invesco Ltd. | SMLP Summit Midstream Partners, LP | 13G/A | 0% | Aug 30, 2024 | 2y |
| Capital World Investors | RVNC Revance Therapeutics, Inc. | 13G/A | 6.6% | Aug 30, 2024 | 2y |
| Karpus Management, Inc. | NAD Nuveen Quality Municipal Income Fund | 13G/A | 4.8% | Aug 30, 2024 | 2y |
| EMBRAER S.A. | EVEX Eve Holding, Inc. | 13D/A | 88.5% | Jun 28, 2024 | 2y |
| Embraer Aircraft Holding, Inc. | EVEX Eve Holding, Inc. | 13D/A | 88.5% | Jun 28, 2024 | 2y |
| TRIAN FUND MANAGEMENT, L.P. | WEN Wendy's Co | 13D/A | 15.19% | Sep 6, 2024 | 2y |
| Ying Luo | GYRE Gyre Therapeutics, Inc. | 13D | 8.54% | Sep 6, 2024 | 2y |
| Songjiang Ma | GYRE Gyre Therapeutics, Inc. | 13D | 7.62% | Sep 6, 2024 | 2y |
| Saba Capital Management, L.P. | NPFD Nuveen Variable Rate Preferred & Income Fund | 13D/A | 4.89% | Sep 5, 2024 | 2y |
| Huatai Securities Co., Ltd. | AMK AssetMark Financial Holdings, Inc. | 13D/A | 0% | Sep 5, 2024 | 2y |
| MAK CAPITAL ONE LLC | SKY Champion Homes, Inc. | 13D/A | 4.8% | Sep 5, 2024 | 2y |
| Zall Development Investment Company Limited | LITB LightInTheBox Holding Co., Ltd. | 13D/A | 25.4% | Sep 5, 2024 | 2y |
| Michael A. Davis (“Davis”) | CYAN Cyanotech Corp | 13D/A | 22.8% | Sep 4, 2024 | 2y |
| Focused Compounding Fund, LP | PRKA Parks America, Inc | 13D/A | 40.22% | Sep 4, 2024 | 2y |
| Wax Asset Management, LLC | ASYS Amtech Systems Inc | 13G/A | 11.3% | Aug 31, 2024 | 2y |
| BAILLIE GIFFORD & CO | STAA Staar Surgical Co | 13G/A | 3.18% | Aug 30, 2024 | 2y |
| Goodwood Inc. | CSCIF COSCIENS Biopharma Inc. | 13D | 7.2% | Aug 29, 2024 | 2y |
| Mitchell P. Kopin | RR Richtech Robotics Inc. | 13G | 4.99% | Aug 29, 2024 | 2y |
| Fairmount Funds Management LLC | ORKA Oruka Therapeutics, Inc. | 13D | 19.99% | Aug 29, 2024 | 2y |
| Ramnarain Joseph Jaigobind | SCPX Scorpius Holdings, Inc. | 13G | 9.13% | Aug 20, 2024 | 2y |
| Guy Levy | BCAB BioAtla, Inc. | 13D/A | 5.5% | Aug 19, 2024 | 2y |
| Archon Capital Management LLC | ARAY Accuray Inc | 13G/A | 0.8% | Aug 15, 2024 | 2y |
| BROWN CAPITAL MANAGEMENT LLC | ENFN Enfusion, Inc. | 13G/A | 8.45% | Jul 31, 2024 | 2y |
| David B. Blundin | EVER EverQuote, Inc. | 13D/A | 22.4% | Sep 5, 2024 | 2y |
| HELU CARLOS SLIM | PBF PBF Energy Inc. | 13G/A | 17.6% | Sep 4, 2024 | 2y |
| Point72 Asset Management, L.P. | TDOC Teladoc Health, Inc. | 13G | 5.1% | Sep 4, 2024 | 2y |
| APMH Invest A/S | NE Noble Corp plc | 13D/A | 17.35% | Sep 4, 2024 | 2y |
| HELU CARLOS SLIM | TALO Talos Energy Inc. | 13D/A | 23.8% | Sep 4, 2024 | 2y |
| Galkin Vladimir | JBLU Jetblue Airways Corp | 13D | 10% | Sep 3, 2024 | 2y |
| Riot Platforms, Inc. | KEEL Keel Infrastructure Corp. | 13D/A | 19.9% | Sep 3, 2024 | 2y |
| Core 4 Capital Corp. | BNKK Bonk, Inc. | 13G/A | 19% | Sep 3, 2024 | 2y |
| Adiumentum Capital Fund I LP | ATRA Atara Biotherapeutics, Inc. | 13D/A | 19.99% | Sep 3, 2024 | 2y |
| JENNISON ASSOCIATES LLC | PLYM Plymouth Industrial REIT, Inc. | 13G/A | 10.6% | Aug 31, 2024 | 2y |
| CANADA PENSION PLAN INVESTMENT BOARD | AOMR Angel Oak Mortgage REIT, Inc. | 13G/A | 0% | Aug 31, 2024 | 2y |
| JPMORGAN CHASE & CO | OM Outset Medical, Inc. | 13G/A | 0.2% | Aug 30, 2024 | 2y |
| JPMORGAN CHASE & CO | LASR Nlight, Inc. | 13G/A | 3.4% | Aug 30, 2024 | 2y |
| Voss Capital, LP | IMXI International Money Express, Inc. | 13D | 5.6% | Aug 30, 2024 | 2y |
| JPMORGAN CHASE & CO | PEG Public Service Enterprise Group Inc | 13G/A | 3.7% | Aug 30, 2024 | 2y |
| Harraden Circle Investments, LLC | SKGR SK Growth Opportunities Corporation Class A Common Stock | 13G | 9.94% | Aug 28, 2024 | 2y |
| Archon Capital Management LLC | RRGB Red Robin Gourmet Burgers Inc | 13G/A | 4.4% | Aug 28, 2024 | 2y |
| Joseph Reda | XXII 22nd Century Group, Inc. | 13G/A | 8.3% | Aug 27, 2024 | 2y |